Navigation Links
KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes To Approve Bylaw Amendments
Date:11/13/2009

h the SEC on April 30, 2009, as well as certain other of the Company's SEC filings;
  • the possibility that insurance proceeds are insufficient to cover potential losses that may arise from litigation, including with respect to product liability or securities litigation;
  • the informal inquiry initiated by the SEC and any related or additional governmental investigative or enforcement proceedings, including actions by the FDA and the U.S. Department of Justice, all as more fully described in the Company's Form 8-K filed with the SEC on January 26, 2009, the Company's Form 8-K filed with the SEC on February 26, 2009, the Company's Form 8-K filed with the SEC on April 30, 2009, the Company's Form 8-K filed with the SEC on July 24, 2009 and the Company's Form 8-K filed with the SEC on November 12, 2009;
  • delays in returning, or failure to return, certain or many of the Company's approved products to market, including loss of market share as a result of the suspension of shipments, and related costs;
  • the ability to sell or license certain assets, and the terms of such transactions;
  • the possibility that the auction rate securities held by the Company may not return to liquidity at or near their face value;
  • the ability to monetize the auction rate securities currently held by the Company, the amount of proceeds to be received from such monetization and the timing of receipt of proceeds by the Company;
  • the timing and ability to realize and receive expected tax refunds, the actual refund amount to be received by the Company subject to any challenges or otherwise and the timing of receipt of the refund by the Company;
  • the possibility that default on one type or class of the Company's indebtedness could result in cross default under, and the acceleration of, the Company's other indebtedness;
  • difficulties and uncertainties with respect to obtaining additional capital; and
  • the risks detailed from time
    '/>"/>

  • SOURCE KV Pharmaceutical Company
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. ReSearch Pharmaceutical Services, Inc. Unaudited Quarterly Report for the Period Ended September 30, 2009
    2. Cempra Pharmaceuticals To Present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 17th
    3. Tianyin Pharmaceutical co., Inc. Announces Record First Quarter 2010 Financial Results
    4. Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen by Three Months
    5. Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results
    6. Euro RSCG Life Presents Proprietary Survey Insights at Food and Drug Administration Hearing on Pharmaceutical Promotion via Online and Social Media
    7. Biostar Pharmaceuticals, Inc. Announces Record Third Quarter 2009 Financial Results
    8. Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results
    9. Onyx Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
    10. Webcast Alert: Isis Pharmaceuticals and Genzyme Corporation to Present Mipomersen Phase 3 Data in HoFH During AHA
    11. Endo Pharmaceuticals and LecTec Settle Patent Dispute
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/2/2015)... N.J. , March 2, 2015  Champions Oncology, ... of advanced technology solutions and services to personalize the ... 30 day extension on the $2 million convertible promissory ... December 1, 2014.  Dr. David ... "Champions continues to benefit from the confidence and commitment ...
    (Date:3/2/2015)... VANCOUVER , Canada and HOUSTON, TX ... ("ESSA" or the "Company") (TSX-V: EPI) today reported financial ... December 31, 2014.  Amounts, unless specified otherwise, are expressed ... Reporting Standards (IFRS). Summary Results ... million ($0.10 per common share) for the three months ...
    (Date:3/2/2015)... 2015 Attorney Advertising -- Bronstein, Gewirtz ... behalf of purchasers of the securities of Vitae ... VTAE -News).  Such investors are advised to contact ... coordinator Eitan Kimelman at info@bgandg.com ... whether Vitae Pharmaceuticals and certain of its officers ...
    Breaking Medicine Technology:Champions Oncology Extends Convertible Debt Financing 2Champions Oncology Extends Convertible Debt Financing 3ESSA Pharma Inc. Reports First Quarter 2015 Financial Results 2ESSA Pharma Inc. Reports First Quarter 2015 Financial Results 3ESSA Pharma Inc. Reports First Quarter 2015 Financial Results 4SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Vitae Pharmaceuticals, Inc. 2
    ... N.C., Jan. 26, 2011 MedCath Corporation (Nasdaq: ... closes on February 9, 2011 to announce results from its ... MedCath has elected not to host a conference call to ... Corporation, headquartered in Charlotte, N.C., is a healthcare provider focused ...
    ... 2011 Boston Scientific Corporation (NYSE: BSX ... the PLATINUM China clinical trial, which is designed to ... Element™ Everolimus-Eluting Platinum Chromium Coronary Stent compared to the ... patients with a single de novo atherosclerotic ...
    Cached Medicine Technology:Boston Scientific Begins Clinical Trial Enrollment in China for PROMUS Element™ Everolimus-Eluting Stent 2Boston Scientific Begins Clinical Trial Enrollment in China for PROMUS Element™ Everolimus-Eluting Stent 3Boston Scientific Begins Clinical Trial Enrollment in China for PROMUS Element™ Everolimus-Eluting Stent 4
    (Date:3/2/2015)... (PRWEB) March 02, 2015 Burns ... temperature calibration for Secondary Standard Platinum Resistance Thermometers ... 5 business days or less . . . ... NVLAP ® Accredited (Lab Code 200706-0), ISO 9001 ... Temperature range is -196°C to 500°C, both ...
    (Date:3/2/2015)... Over the last five years the ultrasound market has ... their geographic presence and achieve economies of scale. The ... by 2019 at CAGR of 5.1% from 2014 to ... and a major part of Europe are mature markets ... including China and India, Latin America and the Middle ...
    (Date:3/2/2015)... 2015 This year, the National Multiple Sclerosis ... provide opportunities for people across the country to unite, ... with MS live their best lives. MS Awareness Week is ... others to join the Society’s vision of a world free ... disabling disease of the central nervous system, interrupts the flow ...
    (Date:3/2/2015)... Atlantic Information Services, Inc. (AIS) is ... of Health Plans: 2015 , the all-new 12th edition ... health plan market, with enrollment data and contact information ... , Available as a printed book containing the full ... quick-view tables and charts, as well as an electronic ...
    (Date:3/2/2015)... A true renaissance man—some might call him ... cult rock band Khazad Doom, has long inspired his countless ... despite all odds. His motto throughout his life has always ... goal was before him. And that attitude, born amidst the ... on to a new generation. , As Eadon knows, when ...
    Breaking Medicine News(10 mins):Health News:Burns Engineering Announces Quick-Turn Temperature Calibrations 2Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 2Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 3Health News:Every Connection Counts During MS Awareness Week 2Health News:Every Connection Counts During MS Awareness Week 3Health News:Every Connection Counts During MS Awareness Week 4Health News:Now Available from AIS: 12th Edition of Annual Book Containing Health Plan Enrollment Data, Contact Information 2Health News:Cult Rock Star’s “Got To Make It” Attitude Inspires New Generations 2Health News:Cult Rock Star’s “Got To Make It” Attitude Inspires New Generations 3
    ... Association Intervention Tool Kit Reduces Patient ... Injuries/Repeat Visits and Risky Drinking, DES ... Alcohol Screening Day, 360 nurses in emergency departments,nationwide will ... intervention tool kit designed to address alcohol use,problems with ...
    ... Enhance Flexible Premium Universal ... Life ... many Americans seek financial guarantees. AXA Equitable Life,Insurance Company announced today ... by offering more competitive rates in,approved jurisdictions on its Athena Universal ...
    ... 2008 Principals announced today a $3,billion dollar ... with,chemical manufacturer W.R.Grace & Co. and related entities, ... from bankruptcy,with no further obligations for asbestos injury ... the 1970,s., Terms of the agreement will ...
    ... Stiefel Laboratories,Inc., the world,s largest independent pharmaceutical company ... has been,promoted to the newly created position of ... chief scientific officer will reinforce the,already critical role ... between,all R&D departments. It also will further strengthen ...
    ... mammals (and this naturally includes humans) is an extraordinarily complex ... also to the formation in healthy eyes of elastic and ... the ciliary muscles, the lens can change its degree of ... As a result, a pin sharp image is created on ...
    ... 2008 Quest Diagnostics,Incorporated (NYSE: DGX ), the ... today that it will make public,its first-quarter 2008 results ... it will conduct it,s first quarter investor conference call,at ... may access the conference call through a live audio ...
    Cached Medicine News:Health News:Emergency Departments Nationwide Institute New Alcohol Screening and Intervention Process 2Health News:AXA Equitable Helps Americans Secure Their Financial Future with More Affordable Lapse Protection Coverage 2Health News:AXA Equitable Helps Americans Secure Their Financial Future with More Affordable Lapse Protection Coverage 3Health News:AXA Equitable Helps Americans Secure Their Financial Future with More Affordable Lapse Protection Coverage 4Health News:$3 Billion Asbestos Deal Reached by W.R.Grace Company to Pay Asbestos Victims 2Health News:Stiefel Laboratories Appoints First Chief Scientific Officer 2Health News:Stiefel Laboratories Appoints First Chief Scientific Officer 3Health News:When poor communication pokes you in the eye 2Health News:Quest Diagnostics to Release First Quarter 2008 Financial Results and Conduct Quarterly Investor Conference Call 2
    ... Centuries of German Craftsmanship ... instrumentation in the world. Ocutek ... you! Only holders of the ... and eight-year apprenticeship, are qualified ...
    ... Centuries of German Craftsmanship have ... in the world. Ocutek now ... Only holders of the coveted ... eight-year apprenticeship, are qualified to ...
    ... platform with integrated neck. Piston assembly ... an internal spring to recoil back ... Block fits into precision milled cavity ... sized 6.25 - 9.0mm. Designed for ...
    ... Central platform with integrated neck. ... platform utilizing an internal spring to ... use. Cutting Block fits into precision ... trephine blades sized 6.25 - 9.0mm. ...
    Medicine Products: